Akari Therapeutics (AKTX) Net Income Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -115.33% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -73.01% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -290.15% |
| Dec 31, 2025 | -40.46% |
| Sep 30, 2025 | -121.07% |
| Jun 30, 2025 | 57.74% |
| Mar 31, 2025 | 40.20% |
| Dec 31, 2024 | 25.79% |
| Sep 30, 2024 | -16.22% |
| Jun 30, 2024 | -63.50% |
| Mar 31, 2024 | -31.18% |
| Jun 30, 2023 | 21.10% |
| Mar 31, 2023 | 12.89% |
| Jun 30, 2022 | -34.28% |
| Mar 31, 2022 | 5.51% |
| Dec 31, 2021 | -296,882.56% |
| Sep 30, 2021 | -507.28% |
| Jun 30, 2021 | 26.77% |
| Mar 31, 2021 | -12.57% |
| Dec 31, 2020 | 11.94% |
| Sep 30, 2020 | 92.27% |
| Jun 30, 2020 | 2.00% |
| Mar 31, 2020 | -37,282.70% |
| Dec 31, 2019 | -66.18% |
| Sep 30, 2019 | -6.69% |
| Jun 30, 2019 | 23.77% |
| Mar 31, 2019 | 100.31% |
| Dec 31, 2018 | 65.28% |
| Sep 30, 2018 | 65.63% |
| Jun 30, 2018 | -8.22% |
| Mar 31, 2018 | 48.56% |
| Dec 31, 2017 | -223.46% |
| Sep 30, 2017 | -439.85% |
| Jun 30, 2017 | 2.56% |
| Mar 31, 2017 | -176.16% |
| Dec 31, 2016 | -78.78% |
| Sep 30, 2016 | 96.77% |
| Jun 30, 2016 | -348.99% |
| Mar 31, 2016 | -75.94% |
| Dec 31, 2015 | 4,747.13% |
| Sep 30, 2015 | -21,741.93% |
| Jun 30, 2015 | 25.03% |
| Mar 31, 2015 | 2.48% |